DB1 ESTIMATING THE LONG-TERM CLINICAL AND ECONOMIC BENEFITS OF INSULIN LISPRO IN TYPE 1 DIABETES IN THE UNITED KINGDOM- A COST-EFFECTIVENESS ANALYSIS BASED ON THE RESULTS OF A RECENT META-ANALYSIS
Abstract
Authors
HT Smith WJ Valentine KS Boye A Kalsekar C Pratoomsoot